中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 5
May  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(5): 1039-1043

Research advances in liver macrophages regulating malignant transformation of hepatic precancerous lesions

DOI: 10.12449/JCH240527
  • 1.

    Liver Disease Hospital Ward One，The Affiliated Hospital of Shaanxi University of Chinese Medicine，Xianyang，Shaanxi 712000，China

  • 2.

    First Clinical Medical College，Shaanxi University of Chinese Medicine，Xianyang，Shaanxi 712000，China

  • 3.

    Department of Infectious Diseases，People’s Hospital of Ningxia Hui Autonomous Region，Yinchuan 750002，China

Research funding:

National Natural Science Foundation of China (82174330);

Science and Technology Department of Shaanxi Research Fund (2022JQ-965);

Science and Technology Department of Shaanxi Research Fund (2020ZDLSF05-15);

Innovation Team of Science and Technology Department of Shaanxi Province (2022TD-55);

Innovation Team of TCM Administration of Shaanxi Province (2022-SLRH-LJ-002);

Science and Technology Administration of Xianyang City Scientific Research Fund (L2022ZDYFSF007);

Natural Science Foundation of Ningxia (2023AAC03510);

Discipline Innovation Team Building Project of Shaanxi University of Chinese Medicine (2019-YL05)

More Information
  • Corresponding author: GUO Yingjun， 510410652@qq.com （ORCID： 0009-0007-9766-5955）; LI Jingtao， lijingtao555@163.com （ORCID： 0000-0003-0417-9821）
  • Received Date: 2023-08-15
  • Accepted Date: 2023-09-12
  • Published Date: 2024-05-25
    Abstract
  • Liver macrophages are important immune cells in the liver， and they express proinflammatory factors and anti-inflammatory factors through polarization into M1 type and M2 type， respectively， thereby playing a role in regulating inflammatory damage response. The malignant transformation of hepatic progenitor cells is the core mechanism of the malignant progression of hepatic precancerous lesions， and its key factor is the continuous stimulation of inflammatory microenvironment， which is closely associated with M1/M2 macrophage polarization. This review mainly focuses on the association between macrophage polarization， chronic inflammation， and malignant transformation of hepatic progenitor cells， so as to provide a theoretical basis for the prevention and treatment of hepatic precancerous lesions.

     

    • FullText(HTML)
  • loading
    • References(46)
  • [1]
    VOGEL A, MEYER T, SAPISOCHIN G, et al. Hepatocellular carcinoma[J]. Lancet, 2022, 400( 10360): 1345- 1362. DOI: 10.1016/S0140-6736(22)01200-4.
    [2]
    WANG C, VEGNA S, JIN HJ, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer[J]. Nature, 2019, 574( 7777): 268- 272. DOI: 10.1038/s41586-019-1607-3.
    [3]
    RENZULLI M, BISELLI M, BROCCHI S, et al. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm[J]. Gut, 2018, 67( 9): 1674- 1682. DOI: 10.1136/gutjnl-2017-315384.
    [4]
    JIAO JZ, LI JT, YAN SG, et al. Current research status of precancerous dysplastic nodules in hepatocellular carcinoma[J]. J Clin Hepatol, 2017, 33( 5): 974- 978. DOI: 10.3969/j.issn.1001-5256.2017.05.039.

    焦俊喆, 李京涛, 闫曙光, 等. 肝细胞癌癌前异型增生结节的研究现状[J]. 临床肝胆病杂志, 2017, 33( 5): 974- 978. DOI: 10.3969/j.issn.1001-5256.2017.05.039.
    [5]
    Professional Committee for Prevention and Control of Hepatobiliary and Pancreatic Diseases of Chinese Preventive Medicine Association; Professional Committee for Hepatology, Chinese Research Hospital Association; Chinese Society of Hepatology, Chinese Medical Association, et al. Guideline for stratified screening and surveillance of primary liver cancer(2020 edition)[J]. J Clin Hepatol, 2021, 37( 2): 286- 295. DOI: 10.3969/j.issn.1001-5256.2021.02.009.

    中华预防医学会肝胆胰疾病预防与控制专业委员会, 中国研究型医院学会肝病专业委员会, 中华医学会肝病学分会, 等. 原发性肝癌的分层筛查与监测指南(2020版)[J]. 临床肝胆病杂志, 2021, 37( 2): 286- 295. DOI: 10.3969/j.issn.1001-5256.2021.02.009.
    [6]
    MARQUARDT JU, ANDERSEN JB, THORGEIRSSON SS. Functional and genetic deconstruction of the cellular origin in liver cancer[J]. Nat Rev Cancer, 2015, 15( 11): 653- 667. DOI: 10.1038/nrc4017.
    [7]
    ZHU LQ, FINKELSTEIN D, GAO CL, et al. Multi-organ mapping of cancer risk[J]. Cell, 2016, 166( 5): 1132- 1146. DOI: 10.1016/j.cell.2016.07.045.
    [8]
    MIYAJIMA A, TANAKA M, ITOH T. Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming[J]. Cell Stem Cell, 2014, 14( 5): 561- 574. DOI: 10.1016/j.stem.2014.04.010.
    [9]
    BRIA A, MARDA J, ZHOU JM, et al. Hepatic progenitor cell activation in liver repair[J]. Liver Res, 2017, 1( 2): 81- 87. DOI: 10.1016/j.livres.2017.08.002.
    [10]
    WU CC, LIN CJ, KUO KK, et al. Correlation between cancer stem cells, inflammation and malignant transformation in a DEN-induced model of hepatic carcinogenesis[J]. Curr Issues Mol Biol, 2022, 44( 7): 2879- 2886. DOI: 10.3390/cimb44070198.
    [11]
    PU WJ, ZHU H, ZHANG MJ, et al. Bipotent transitional liver progenitor cells contribute to liver regeneration[J]. Nat Genet, 2023, 55( 4): 651- 664. DOI: 10.1038/s41588-023-01335-9.
    [12]
    LIU WT, GAO L, HOU XJ, et al. TWEAK signaling-induced ID1 expression drives malignant transformation of hepatic progenitor cells during hepatocarcinogenesis[J]. Adv Sci, 2023, 10( 18): e2300350. DOI: 10.1002/advs.202300350.
    [13]
    NIO K, YAMASHITA T, KANEKO S. The evolving concept of liver cancer stem cells[J]. Mol Cancer, 2017, 16( 1): 4. DOI: 10.1186/s12943-016-0572-9.
    [14]
    THAN NN, NEWSOME PN. Stem cells for liver regeneration[J]. QJM, 2014, 107( 6): 417- 421. DOI: 10.1093/qjmed/hcu013.
    [15]
    YAN ZJ, CHEN L, WANG HY. To be or not to be: The double-edged sword roles of liver progenitor cells[J]. Biochim Biophys Acta Rev Cancer, 2023, 1878( 3): 188870. DOI: 10.1016/j.bbcan.2023.188870.
    [16]
    SIA D, VILLANUEVA A, FRIEDMAN SL, et al. Liver cancer cell of origin, molecular class, and effects onPatient prognosis[J]. Gastroenterology, 2017, 152( 4): 745- 761. DOI: 10.1053/j.gastro.2016.11.048.
    [17]
    HAIDERI SS, MCKINNON AC, TAYLOR AH, et al. Injection of embryonic stem cell derived macrophages ameliorates fibrosis in a murine model of liver injury[J]. NPJ Regen Med, 2017, 2: 14. DOI: 10.1038/s41536-017-0017-0.
    [18]
    ZENG JX, JING YY, WU QL, et al. Autophagy is required for hepatic differentiation of hepatic progenitor cells via Wnt signaling pathway[J]. Biomed Res Int, 2021, 2021: 6627506. DOI: 10.1155/2021/6627506.
    [19]
    NATI M, CHUNG KJ, CHAVAKIS T. The role of innate immune cells in nonalcoholic fatty liver disease[J]. J Innate Immun, 2022, 14( 1): 31- 41. DOI: 10.1159/000518407.
    [20]
    KHURANA A, NAVIK U, ALLAWADHI P, et al. Spotlight on liver macrophages for halting liver disease progression and injury[J]. Expert Opin Ther Targets, 2022, 26( 8): 707- 719. DOI: 10.1080/14728222.2022.2133699.
    [21]
    SOUCIE EL, WENG ZM, GEIRSDÓTTIR L, et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells[J]. Science, 2016, 351( 6274): aad5510. DOI: 10.1126/science.aad5510.
    [22]
    BLÉRIOT C, DUPUIS T, JOUVION G, et al. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection[J]. Immunity, 2015, 42( 1): 145- 158. DOI: 10.1016/j.immuni.2014.12.020.
    [23]
    VANNELLA KM, WYNN TA. Mechanisms of organ injury and repair by macrophages[J]. Annu Rev Physiol, 2017, 79: 593- 617. DOI: 10.1146/annurev-physiol-022516-034356.
    [24]
    LUO Y, XIAO JH. Inflammatory auxo-action in the stem cell division theory of cancer[J]. PeerJ, 2023, 11: e15444. DOI: 10.7717/peerj.15444.
    [25]
    LI XF, CHEN C, XIANG DM, et al. Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance[J]. Hepatology, 2017, 66( 6): 1934- 1951. DOI: 10.1002/hep.29372.
    [26]
    SICA A, INVERNIZZI P, MANTOVANI A. Macrophage plasticity and polarization in liver homeostasis and pathology[J]. Hepatology, 2014, 59( 5): 2034- 2042. DOI: 10.1002/hep.26754.
    [27]
    MURRAY PJ, ALLEN JE, BISWAS SK, et al. Macrophage activation and polarization: Nomenclature and experimental guidelines[J]. Immunity, 2014, 41( 1): 14- 20. DOI: 10.1016/j.immuni.2014.06.008.
    [28]
    SHAPOURI-MOGHADDAM A, MOHAMMADIAN S, VAZINI H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233( 9): 6425- 6440. DOI: 10.1002/jcp.26429.
    [29]
    JIN K, LI T, SÁNCHEZ-DUFFHUES G, et al. Involvement of inflammation and its related microRNAs in hepatocellular carcinoma[J]. Oncotarget, 2017, 8( 13): 22145- 22165. DOI: 10.18632/oncotarget.13530.
    [30]
    YANG L, ZHANG Y. Tumor-associated macrophages: From basic research to clinical application[J]. J Hematol Oncol, 2017, 10( 1): 58. DOI: 10.1186/s13045-017-0430-2.
    [31]
    MAO YL, WANG BK, XU X, et al. Glycyrrhizic acid promotes M1 macrophage polarization in murine bone marrow-derived macrophages associated with the activation of JNK and NF-κB[J]. Mediators Inflamm, 2015, 2015: 372931. DOI: 10.1155/2015/372931.
    [32]
    TANG Y, KITISIN K, JOGUNOORI W, et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling[J]. Proc Natl Acad Sci U S A, 2008, 105( 7): 2445- 2450. DOI: 10.1073/pnas.0705395105.
    [33]
    HAN CY, YANG Y, SHENG YJ, et al. The mechanism of lncRNA-CRNDE in regulating tumour-associated macrophage M2 polarization and promoting tumour angiogenesis[J]. J Cellular Molecular Medi, 2021, 25( 9): 4235- 4247. DOI: 10.1111/jcmm.16477.
    [34]
    GUNASSEKARAN GR, POONGKAVITHAI VADEVOO SM, BAEK MC, et al. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages[J]. Biomaterials, 2021, 278: 121137. DOI: 10.1016/j.biomaterials.2021.121137.
    [35]
    ORECCHIONI M, GHOSHEH Y, PRAMOD AB, et al. Macrophage polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages[J]. Front Immunol, 2019, 10: 1084. DOI: 10.3389/fimmu.2019.01084.
    [36]
    RINGELHAN M, PFISTER D, O’CONNOR T, et al. The immunology of hepatocellular carcinoma[J]. Nat Immunol, 2018, 19( 3): 222- 232. DOI: 10.1038/s41590-018-0044-z.
    [37]
    Bureau of Medical Administration, National Health Commission of the People’s Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China(2019 edition)[J]. J Clin Hepatol, 2020, 36( 2): 277- 292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.

    中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36( 2): 277- 292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
    [38]
    CHEN JM, CHEN L, ZERN MA, et al. The diversity and plasticity of adult hepatic progenitor cells and their niche[J]. Liver Int, 2017, 37( 9): 1260- 1271. DOI: 10.1111/liv.13377.
    [39]
    HOU XJ, YE F, LI XY, et al. Immune response involved in liver damage and the activation of hepatic progenitor cells during liver tumorigenesis[J]. Cell Immunol, 2018, 326: 52- 59. DOI: 10.1016/j.cellimm.2017.08.004.
    [40]
    KAUR S, SIDDIQUI H, BHAT MH. Hepatic progenitor cells in action: Liver regeneration or fibrosis?[J]. Am J Pathol, 2015, 185( 9): 2342- 2350. DOI: 10.1016/j.ajpath.2015.06.004.
    [41]
    ALEKSANDROVA K, BOEING H, NÖTHLINGS U, et al. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer[J]. Hepatology, 2014, 60( 3): 858- 871. DOI: 10.1002/hep.27016.
    [42]
    YANG X, SHAO CC, DUAN LX, et al. Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-Α[J]. Cancer Lett, 2021, 517: 46- 54. DOI: 10.1016/j.canlet.2021.05.039.
    [43]
    LI L, CUI L, LIN P, et al. Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers[J]. Cell Stem Cell, 2023, 30( 3): 283- 299. e 9. DOI: 10.1016/j.stem.2023.01.009.
    [44]
    GALDIERO MR, BONAVITA E, BARAJON I, et al. Tumor associated macrophages and neutrophils in cancer[J]. Immunobiology, 2013, 218( 11): 1402- 1410. DOI: 10.1016/j.imbio.2013.06.003.
    [45]
    GOSWAMI KK, GHOSH T, GHOSH S, et al. Tumor promoting role of anti-tumor macrophages in tumor microenvironment[J]. Cell Immunol, 2017, 316: 1- 10. DOI: 10.1016/j.cellimm.2017.04.005.
    [46]
    van HUL N, LANTHIER N, ESPAÑOL SUÑER R, et al. Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury[J]. Am J Pathol, 2011, 179( 4): 1839- 1850. DOI: 10.1016/j.ajpath.2011.06.042.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (420) PDF downloads(38) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return